Boston Scientific Corp. (BSX) News

Boston Scientific Corp. (BSX): $52.10

0.73 (-1.38%)

POWR Rating

Component Grades








Filter BSX News Items

BSX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

BSX News Highlights

  • BSX's 30 day story count now stands at 22.
  • Over the past 27 days, BSX's stories per day has been in a clear uptrend, growing by about 0.14 per day.
  • CVS, TOP and DRUG are the most mentioned tickers in articles about BSX.

Latest BSX News From Around the Web

Below are the latest news stories about BOSTON SCIENTIFIC CORP that investors may wish to consider to help them evaluate BSX as an investment opportunity.

The Zacks Analyst Blog Highlights, Boeing, Regeneron, Boston Scientific and Waste Management, Boeing, Regeneron, Boston Scientific and Waste Management are part of the Zacks top Analyst Blog.

Yahoo | September 25, 2023

Boston Scientific (BSX) Set to Acquire Relievant Medsystems

Boston Scientific's (BSX) new M&A deal is likely to broaden the Neuromodulation business portfolio.

Yahoo | September 25, 2023

What Is the Boston Scientific Foundation?

NORTHAMPTON, MA / ACCESSWIRE / September 21, 2023 / Boston ScientificAs a leader in health care, Boston Scientific is dedicated to creating healthier communities in a wealth of ways, including large-scale programs like Close the Gap that help increase ...

Yahoo | September 21, 2023

CVS Health appoints Michael F. Mahoney to its Board of Directors

CVS Health Corporation (NYSE: CVS) has appointed Michael F. Mahoney, Chairman and CEO of Boston Scientific Corporation (NYSE: BSX), a global medical technology leader, to serve on the Board of Directors (the "Board") of CVS Health, effective November 1.

Yahoo | September 21, 2023

Boston Scientific Offers Bullish Guidance And Briefly Breaks Out

Boston Scientific kicked off its Investor Day on Wednesday, a day after announcing its Relievant buyout, and BSX stock jumped.

Yahoo | September 20, 2023

Is Boston Scientific (BSX) Priced Right? A Comprehensive Guide to Its Market Value

Unveiling the True Worth of Boston Scientific (BSX) Through a Detailed Analysis of Its Valuation and Financial Performance

Yahoo | September 20, 2023

Health Care Roundup: Market Talk

Find insight on Boston Scientific, Praxis Precision Medicines, Pfizer, and more in the latest Market Talks covering the Health Care sector.

Yahoo | September 19, 2023

6 Growth Stocks That Look Recession-Resistant, According to Morgan Stanley

Apple, Boston Scientific, Costco, Monster Beverage, UnitedHealth, and Colgate-Palmolive shares could still rise in the face of a consumer-spending slump, says Morgan Stanley.

Yahoo | September 19, 2023

Midday movers: Instacart, AutoZone, Target and more -- U.S. were falling on Tuesday as investors await the start of the crucial two-day Federal Reserve meeting, which could set the tone for weeks to come.

Yahoo | September 19, 2023

UPDATE 2-Boston Scientific to buy chronic back pain therapy maker Relievant

Medical devices maker Boston Scientific said on Tuesday it would buy private medical tech company Relievant Medsystems for an upfront cash payment of $850 million, gaining access to an FDA-cleared therapy for chronic pain. The Massachusetts-based company is also obliged to pay Relievant additional undisclosed payments based on sales performance over the next three years. The deal is the latest in a string of acquisitions by Boston Scientific, which makes pacemakers, stents and catheters, to boost its portfolio of devices.

Yahoo | September 19, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!